LOXL2 Inhibitors and Breast Cancer Progression
LOX (lysyl oxidase) and lysyl oxidase like-1–4 (LOXL 1–4) are amine oxidases, which catalyze cross-linking reactions of elastin and collagen in the connective tissue. These amine oxidases also allow the cross-link of collagen and elastin in the extracellular matrix of tumors, facilitating the proces...
Main Authors: | Sandra Ferreira, Nuno Saraiva, Patrícia Rijo, Ana S. Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/2/312 |
Similar Items
-
LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
by: Eva P. Cuevas, et al.
Published: (2014-01-01) -
LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression
by: Ji-Wei Jiao, et al.
Published: (2022-11-01) -
Knock-Out of the Five Lysyl-Oxidase Family Genes Enables Identification of Lysyl-Oxidase Pro-Enzyme Regulated Genes
by: Tatyana Liburkin-Dan, et al.
Published: (2022-09-01) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
by: Sylvain D. Vallet, et al.
Published: (2020-12-01) -
Lack of association between lysyl oxidase-like 1 polymorphisms and primary open angle glaucoma:a meta-analysis
by: Wen Sun, et al.
Published: (2014-06-01)